Articles tagged with "upadacitinib"

Upadacitinib Safety Similar to Other Jakinibs for RA

November 16, 2020 • By Lisa Rapaport

RA Patients Taking Either 15 mg or 30 mg Dose of Upadacitinib Experience Improvement

October 1, 2020 • By Arthritis & Rheumatology

FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution

September 30, 2020 • By Michele B. Kaufman, PharmD, BCGP

Janus kinase 1 protein.

Researchers Give Update on Janus Kinase (JAK) Inhibitors

May 15, 2020 • By Kimberly Retzlaff

FDA Update: New Drug Approvals, New & Expanded Indications, & More

March 12, 2020 • By Susan Bernstein

Canada & E.U. Approve Upadacitinib for RA

January 28, 2020 • By Michele B. Kaufman, PharmD, BCGP

Rituximab-abbs Available in the U.S.; Plus Upadacitinib in Phase 3 Trials for PsA

November 25, 2019 • By Michele B. Kaufman, PharmD, BCGP

New Options for Treatment-Resistant RA

October 14, 2019 • By Carina Stanton

FDA Approves Upadacitinib for RA

September 2, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves AbbVie’s New Rheumatoid Arthritis Drug

August 19, 2019 • By Reuters Staff